Elizabeth Arden Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Elizabeth Arden Inc.
Previously intended for Coty under its merger deal with P&G, the Christina Aguilera fragrance license increases Elizabeth Arden's exposure to the vagaries of the celebrity-scent market, but could offer a boost to its European business. The firm reported growing sales in the third quarter, excluding currency effects, as its turnaround progresses.
Formerly assistant general counsel and currently chair of strategic industry categories at the Personal Care Products Council, Farah Ahmed will start as CEO of the International Fragrance Association North America April 18. More people news in brief.
LUXE Brands and Fekkai Brands, which the former created through a joint venture earlier this year to acquire the Frederic Fekkai brand from P&G, will be led by Joel Ronkin, who has left Elizabeth Arden after 16 years of service. More people news.
CFSAN and Office of Cosmetics and Colors leadership heard from the Environmental Working Group on proposed cosmetics legislation at a recent meeting in College Park, Md. More news in brief.
- OTC, Consumer